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KESAN ANTIPROLIFERATIVE OLEH ORTHOSIPHON STAMINEUS  
DAN MADU TUALANG KE ATAS SEL-SEL SKUAMOS KARSINOMA   
ORAL DAN OSTEOSARKOMA MANUSIA 
ABSTRAK 
Kanser adalah penyebab keempat kematian di Malaysia dan hampir 30,000 orang 
menghidap masalah ini setiap tahun. Salah satu bidang penyelidikan yang penting 
adalah kesan tumbuhan dan produk semulajadi sebagai agen kemoterapeutik yang 
efektif. Madu telah menunjukkan spektrum  ciri terapeutik yang luas serta banyak 
kegunaan termasuk kesan  antibaketria, antikulat, antikeradangan dan kesan 
antikanser yang sederhana. Ia mengandungi banyak bahan yang aktif secara biologi 
seperti asid caffeic, ester fenetil dan glikon flavanoid yang telah terbukti menghalang 
sel tumor membiak.  Orthosiphon stamineus (O. stamineus) atau ‘misai kucing’ pula 
adalah herba tradisional yang popular diguna sebagai ubat herba sejak beberapa 
abad. Ia mempunyai ciri perubatan seperti aktiviti antioksidan, antikulat, diuretik, 
antidiabetik dan antikeradangan. Tidak ada kajian yg dpt telah dilakukan untuk 
menilai pengaruh madu Tualang dan O. stamineus ke atas sel-sel skuamos karsinoma 
oral (OSCC) and osteosarkoma manusia (HOS). Kajian ini bertujuan mengesahkan 
aktiviti antiproliferatif madu Tualang, O. stamineus dan beberapa kepekatan 
campuran madu Tualang dan O. stamineus ke atas OSCC dan HOS. 
Beberapa dos madu Tualang (1-20%), O. stamineus (100µg/ml - 1mg/ml) dan 
beberapa kepekatan campuran kedua-duanya diuji ke atas kultur sel OSCC dan HOS 
untuk tempoh 3, 6, 12, 24, 48 and 72 jam. Ciri morfologi apoptosis dilihat dengan 
mikroskop cahaya dan stain Hoechst 33258 di bawah mikroskop fluoresen. Viabiliti 
sel diuji dengan pembenihan dan tambahan dos madu, O. stamineus dan beberapa 
kepekatan kedua-dua campuran. Selepas inkubasi, Metil Tiazol Tetrazolium (MTT) 
ditambah dan sel-sel diinkubasi untuk 4 jam lagi pada suhu 37°C sebelum 
xiii 
 
penambahan dimetil sulfoksid (DMSO).  Analisis dibuat dengan alat  ELISA pada 
absorban 570nm. Semua ujikaji dijalankan dalam triplikat. Apoptosis awal dikesan 
dengan aliran sitometri mengguna Kit Apoptosis I ApoAlert® Annexin V-FITC. 
Untuk kesan madu, aktiviti madu bukan peroksida dan cecair osmolar dibuat sebagai 
tambahan kepada ujian kesan selektif. Gambaran morfologi menunjukkan 
fragmentasi dan kondensasi kromatin nukleus seiring  dengan pengurangan bilangan 
sel dan kesan ini bergantung kepada tempoh dan kepekatan bahan ujian yang 
ditambah. Bahan ujian menunjukkan kesan pertumbuhan inhibitori yang signifikan 
ke atas sel OSCC dan HOS. Ujian viabiliti sel menunjukkan kesan inhibitori yang 
bergantung kepada dos dan masa. Konsentrasi inhibitori 50% (IC50) bagi OSCC dan 
HOS untuk madu Tualang adalah 4% and 3%, untuk O. stamineus adalah 700 dan 
200 µg/ml dan campuran 0.35mg/ml O. stamineus + 3.5% madu Tualang untuk 
OSCC dan campuran 0.2mg/ml O. stamineus + 2% madu Tualang untuk HOS. 
Viabiliti sel menurun dengan peningkatan dos madu sekaligus mengesahkan kesan 
inhibitori madu ke atas kedua-dua sel OSCC dan HOS. Apoptosis awal jelas dilihat 
dengan aliran sitometri dan kesan ini adalah bergantung kepada masa dan kepekatan 
cecair campuran. Oleh itu madu Tualang, O. stamineus dan beberapa kepekatan 
tertentu campuran madu Tualang dan O. stamineus menunjukkan kesan 
antiproliferatif dan apoptosis ke atas sel-sel OSCC dan HOS. 
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ANTIPROLIFERATIVE EFFECTS OF THE ORTHOSIPHON STAMINEUS 
AND TUALANG HONEY ON ORAL SQUAMOUS CELL CARCINOMA 
AND HUMAN OSTEOSARCOMA CELL LINES  
 
ABSTRACT 
Cancer is the fourth leading cause of death in Malaysia with almost 30,000 people 
contracting the disease annually. One of the important research fields is the 
beneficial effects of plants and natural products as effective chemotherapeutic agents. 
Honey exhibits a broad spectrum of therapeutic properties including antibacterial, 
antifungal, anti-inflammatory and moderate anticancer effects. It contains many 
biologically active compounds such as caffeic acid, caffeic acid phenethyl ester and 
flavonoid glycones which have been proven to exhibit inhibitory effect on tumor cell 
proliferation. Orthosiphon stamineus (O. stamineus) or ‘misai kucing’ is a popular 
traditional folk medicine used as medicinal herb for many centuries. It has many 
medicinal properties such as antioxidant activity, antifungal activity, diuretic activity, 
antidiabetic activity, anti-inflammatory activity. No previous study has been done to 
evaluate the effect of Tualang honey and O. stamineus on oral squamous cell 
carcinoma (OSCC) and human osteosarcoma (HOS). This study was aimed to verify 
the antiproliferative activity for several concentrations of Tualang honey, O. 
stamineus and mixed concentrations of honey and O. stamineus on OSCC and HOS 
cell lines. Several doses of Tualang honey (1% - 20%), several concentrations of O. 
stamineus (100µg/ml to 1mg/ml) and several mixed solutions of both were applied 
on OSCC and HOS cell culture for 3, 6, 12, 24, 48 and 72 hours. Morphological 
characteristics were assessed under light microscopy and with Hoechst stain 33258 
under fluorescence microscope. Cell viability assay was performed whereby OSCC 
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and HOS cell lines were seeded in 96-well plates and doses of treatment were added. 
After incubation period, Methyl Thiazole Tetrazolium (MTT) was added and 
incubated for a further 4 hours at 37°C prior to addition of dimethyl sulfoxide 
(DMSO). Analysis was done by using ELISA reader at absorbance 570nm. All 
experiments were performed in triplicates. Detection of early apoptosis was done 
using ApoAlert® Annexin V-FITC Apoptosis Kit I for flow cytometry. For honey 
the non-peroxidase honey activity and osmolar solution control was examined in 
addition to selectivity effect. 
Morphological appearance showed fragmented and nuclear chromatin condensation 
with reduction in cell number depending on time and concentration of treatment 
applied. Treatments showed significant growth inhibitory effect on OSCC and HOS. 
Cell viability assay showed a dose and time-dependent inhibitory effect on both cell 
lines. The 50% inhibitory concentration (IC50) was 4% and 3% for Tualang honey, 
700 and 200µg/ml for O. stamineus and (0.35mg/ml O. stamineus + 3.5% Tualang 
honey) and (0.2mg/ml O. stamineus + 2% Tualang honey) for mixed solutions of O. 
stamineus and honey on OSCC and HOS respectively. Cell viability decreased as the 
dosage of honey was increased showing growth inhibition effect of honey on both 
cell lines. Early apoptosis was evident by flow cytometry. This effect was time and 
concentration-dependent. In conclusion O. stamineus alone have weak 
antiproliferative effect while Tualang honey and several specific concentrations of 
mixed solutions have good antiproliferative and apoptotic effect on OSCC and HOS 
cell lines. 
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CHAPTER ONE 
INTRODUCTION 
 
 
In Malaysia, cancer is the fourth leading cause of death. Almost 30,000 people contract 
the disease each year, with lung cancer being the most common. Most patients are 
diagnosed with cancer during the late stages of the disease. Programs are focused to 
combat cancer, including early diagnosis, treatment, and palliative care, and to improve 
the quality of life of cancer patients (Lim, 2002). In standardized incidence rate for all 
cancers in the year 2003 was 134.3 per 100,000 males and 154.2 per 100,000 females 
(Chye and Yahaya, 2004). 
 
Over the centuries, no fewer than 3,000 plant species have been used to treat cancer. 
Worldwide use of these plants products generated untold wealth, relieved much 
suffering and saved millions of lives. Furthermore, the use of herbal drugs from these 
plants led to the successful habitation of vast areas of tropical to warm temperate 
regions, making possible new opportunities for progress and riches (Lewis and Elvin-
Lewis, 2003).  
 
Flavonoids are a group of more than 5000 polyphenolic compounds that occur naturally 
in foods of plant origin. These compounds possess a common phenylbenzopyrone 
structure (C6–C3–C6), and are categorized according to the saturation level and opening 
of the central pyran ring, mainly into flavones, flavanols, isoflavones, flavonols, 
flavanones and flavanonols (Harborne and Williams, 2000; Ren et al., 2003). These 
polyphenolic compounds have several biological activities that include antimutagenic, 
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antiproliferative, and antioxidant effects as well as involvement in cell signaling, cell 
cycle regulation and angiogenesis (Nijveldt et al., 2001).  
 
Most of the researches for new drugs to be used in oncology have refocused on natural 
products, which led to the finding of some new compounds such as taxanes and 
camptothecins (anticancer drugs derived from plants). In particular, interest has 
intensified on the class of flavonoid compounds present in normal human diet and in 
many folk medicines still in use. Flavonoids and flavonoid-rich extracts have been 
implicated as beneficial agents in a multitude of disease states (Havsteen, 2002). 
 
Dietary flavonoids have preventive and therapeutic potential against malignant tumors 
(Horinaka et al., 2006) and some pharmacological studies have demonstrated that 
flavonoids possess antiproliferation effects of tumor cells and induces cell apoptosis 
(Hsu et al., 2004). Dietary flavonoids have been demonstrated to exert several beneficial 
biological activities in various cell types such as anti-inflammation, antioxidation, 
antiproliferation and pro-apoptosis (Ross and Kasum, 2002). 
 
Examples of commercialized plant products, Vinblastine (VLB) and Vincristine (VCR) 
are powerful anticancer drugs in the treatment of acute leukemia, lymphomas, 
rhabdomyosarcomas, and Wilma‟s tumors in children, Hodgkin's disease, non-Hodgkin 
lymphomas, testis carcinomas, breast cancer and choriocarcinomas. During the last 40 
years, these drugs have been used for the treatment and cure of thousands of patients, 
both because of their unique mode of action and their effectiveness. VLB and VCR are 
natural products belonging to the group of terpenoid-indole alkaloids. They are isolated 
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from the pan tropical plant Cathranths. roseus (Madagascar periwinkle, formerly known 
as Vinca rosea), in which they are present only as minor constituents of the complex 
mixture of about 130 alkaloids produced by this plant (van Der Heijden et al., 2004).  
 
Apoptosis is a mechanism by which cells undergo death to control cell proliferation or in 
response to DNA damage. The basis of this study was to find out the antiproliferative 
and apoptotic effect of O. stamineus and Tualang honey, which may be beneficial in 
anticancer therapy.  
 
Apoptosis is one of the two mechanisms by which cell death occurs (the other being the 
pathological process of necrosis). It is the mechanism responsible for the physiological 
deletion of cells and appears to be intrinsically programmed. It is characterized by 
distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at 
regularly spaced sites and the endonucleolytic cleavage of genomic DNA or DNA 
fragmentation at internucleosomal sites. This mode of cell death serves as a balance to 
mitosis in regulating the size of animal tissues and in mediating pathologic processes 
associated with tumor growth (NIH, 2004). 
 
Cell death has been shown to occur by two major mechanisms namely, necrosis and 
apoptosis. Classical necrotic cell death occurs due to noxious injury or trauma, while 
apoptosis takes place during normal cell development, regulating cellular differentiation 
and number. While necrotic cell death results in cell lysis, cellular apoptosis is 
characterized morphologically by cell shrinkage, nuclear pyknosis, chromatin 
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condensation and blebbing of the plasma membrane. It seems that all known anticancer 
drugs kill cancer cells predominantly through apoptosis (Bremer et al., 2006). 
1.2 Statement of the problem 
The use of herbal extracts and natural products as a complementary to modern medicine 
is gaining increased popularity, while knowledge about the beneficial effects of certain 
materials is mainly transmitted by personal communication. Therefore, it remains 
unknown to the general population. Several studies on anticancer effects of herbal 
extracts and natural products using cancer cell lines suggested that more studies are 
needed to promote the usage and application of herbs for anticancer purposes. To the 
knowledge of the authors, there are no previous experiments to evaluate the effects of O. 
stamineus and Tualang honey on OSCC and HOS cell lines. 
1.3 Justification of study 
The main challenges in cancer treatment strategy are producing curative medicine with 
less side effects and the use of available raw materials. Therefore, there is a great need 
for more experimental research to find natural substitutes in chemotherapy. The 
literatures, some past and ongoing researches have focused on the medicinal effects of 
these plants and natural products.  
 
There is need for clarifying scientifically the anticancer effect of these local herbs and 
honey. This may open other extensions in researches for their good use. Thus, the 
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exploration of cell death induced by these materials will be valuable to design more 
effective chemotherapeutic agents. 
 
There is thus a great need for detailed scientific clarification of the anticancer effects of 
O. stamineus and Tualang honey. These effects may enlighten new research areas for the 
exploration of the beneficial effects of plants and natural products as affective 
chemotherapeutic agents, there are no previous experiments to evaluate the effects of O. 
stamineus and Tualang honey on OSCC and HOS cell lines. 
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1.4 Objectives 
1.4.1 General objective 
To assess the antiproliferative effect and apoptotic activity of Orthosiphon stamineus, 
Tualang honey and a mixture of these products on Oral Tongue Squamous Cell 
Carcinoma and Human Osteosarcoma cell lines. 
1.4.2 Specific objectives 
1.  To evaluate the morphological changes on Oral Squamous Cell Carcinoma and 
Human Osteosarcoma cell lines induced by Orthosiphon stamineus, Tualang honey and 
mixtures of these products under light and flourocense microscope. 
2.  To evaluate the antiproliferative activity of Orthosiphon stamineus, Tualang honey 
and mixtures of these products on Oral Squamous Cell Carcinoma and Human 
Osteosarcoma cell lines by Methyl Thiazole Tetrazolium (MTT) assay. 
3.  To evaluate the apoptotic effect of Orthosiphon stamineus, Tualang honey and 
mixtures of these products on Oral Squamous Cell Carcinoma and Human Osteosarcoma 
cell lines by flow cytometry. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Orthosiphon stamineus Benth 
Orthosiphon stamineus Benth (O. stamineus), which belongs to the Lamiaceae family, is 
a  native plant in tropical Asia. It is a popular medicinal herb in Southeast Asia, known 
locally as „„Misai kucing‟‟ or „„Kumis kucing‟‟ in Malaysia and Singapore or “cat 
whiskers”. It grows well on wet soil and can be found in both temperate and tropical 
gardens (Leng and Keng, 2004). 
 
                                       Fig. 2.1 O. stamineus plant (http://misaikucing.tripod.com) 
2.1.1 Traditional medicinal uses  
O. stamineus is a popular traditional folk medicine that has been used as medicinal herbs 
for many centuries in Southeast Asian countries like Indonesia and Malaysia. It is used 
as a remedy for catarrh of the bladder and as a medicine for various disorders such as 
nephritis, nephrolithiasis, hydronephrosis, vesicle calculi, arteriosclerosis, gout, jaundice 
and rheumatism.  
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In Malaysia, the tea prepared from the leaves is taken as a beverage to improve health 
and to treat kidney and liver disease, bladder inflammation, diabetes, hypertension, 
tonsillitis and menstrual disorder (Eisai, 1995; Awale et al., 2003a; Yam et al., 2007). In 
the  aerial part of Vietnam this plant is known by the name  “Rau meo” and used for the 
treatment of urinary lithiasis, edema, eruptive fever, influenza, hepatitis, jaundice (Tran, 
1990).  
 
In Myanmar, this plant is known as “Secho” or “Myit-shwe”. The leaves are reputed to 
be an antidiabetic drug and decoctions of the air-dried leaves are used to cure eruptive 
fever, epilepsy, gallstone, hepatitis, rheumatism, hypertension, syphilis, gonorrhea and 
renal calculus (Bwin and Gwan, 1967). 
 
It is reported that O. stamineus leaves have been introduced in to Europe and Japan as a 
health tea. According to traditional phytotherapy, O. stamineus tea is beneficial in 
removing uric acid stones from kidney and has been reported to be active against kidney 
and bladder inflammation because of its diuretic activity. It is also used for the treatment 
of diabetes and hypertension (Leng and Keng, 2004). 
2.1.2 Antioxidant activity  
Methanolic extract of O. stamineus samples collected from different places in Malaysia 
have been studied. Twenty phenolic compounds were isolated from O. stamineus extract 
and showed antioxidant properties for phenolic compounds of all samples (Akowuah et 
al., 2004). It was concluded that O. stamineus leaf extract possessed antioxidant and free 
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radical scavenging activities and has a protective effect on hepatic damage (Yam et al., 
2007). 
2.1.3 Antifungal activity   
Sixty nine compounds were identified from crude methanolic extract of leaves and stems 
of O. stamineus. The essential oils and crude extract have an antifungal effect against 
phytopathogens that cause severe diseases in the plants. It was also found that the crude 
methanol extract of O. stamineus showed higher antifungal effect than essential oils 
(Hossain et al., 2008). 
2.1.4 Diuretic activity 
Several classes of compounds have been identified from O. stamineus including 
flavonoids, terpenoids, saponins, hexoses, organic acids, caffeic acid derivatives, 
chromene and myo-inositol (Tezuka et al., 2000; Olah et al., 2003). Among these 
compounds, the flavonoids and caffeic acid derivatives were found to possess potential 
therapeutic properties, as they were shown to exert diuretic and uricosuric actions in rats 
(Olah et al., 2003). The main flavonoids in O. stamineus extract 0.15%, 0.21% and 
0.05%; (w/w) of sinensitin, eupatorin and 3(-hydroxy-5,6,7,4)-tetramethoxyflavone, 
respectively and was analysed by the plasma oral bioavailability  in rats (Loon et al., 
2005). 
 
The main polyphenols (flavonoids): sinesetine, eupatorine, rosmarinic-, cichoric- and 
caffeic-acids were identified and quantitatively determined in O. stamineus and tested on 
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rats for pharmacological action as diuretic and uricosuric (increase volume of urine – 
increase uric acid excretion) were proven by Olah et al (2003).  Arafat et al (2008) 
showed the high tendency of O. stamineus towards diuretic property and provided 
evidence for hypouricemic (reduced uric acid formation) activity of O. stamineus extract 
using animal models. 
 
Sodium citrate is a known inhibitor of calcium oxalate crystal formation that forms 
kidney stones. In-vitro study conducted to compare the effect of  sodium citrate and O. 
stamineus extract found that the O. stamineus extract was a more powerful  inhibitor for 
calcium oxalate crystal formation  than sodium citrate (Dharmaraj et al., 2006). 
2.1.5 Antidiabetic activity 
 One study in Thailand determined that the total phenolic compound in 1 gram of O. 
stamineus extract contained 13.24±0.33mg gallic acid and 1.73±0.147µg flavonoids. 
The authors evaluated the effect of the extract on normal and diabetic rats, where they 
found O. stamineus extract starting from 100µg/ml potentiated glucose-induced insulin 
secretion and in general markedly reduced hyperglycaemia in diabetic rats, decreased 
plasma triglyceride and increased plasma HDL-cholesterol concentrations. These 
findings suggested that O. stamineus extract is useful in the control of diabetes mellitus 
(Sriplang et al., 2007). 
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2.1.6 Anti-inflammatory activity 
Diterpenes were proven to be important compounds extracted from O. stamineus crude 
extract. Awale et al (2003a)  and (2003b) isolated 16 diterpenes from the O. stamineus 
extract and proved their inhibitory effect on nitric oxide production in 
lipopolysaccharide-activated macrophage-like J774.1 cell line (antioxidant effect) which 
verifies the anti-inflammatory activity of O. stamineus. 
 
The same results were proven for 47 diterpenes isolated from O. stamineus extracts from 
Indonesia, Okinawa, Myanmar and Vietnam, all possesing the same inhibitory effect on 
nitric oxide production. MTT assay of cell viability showed that many diterpenes 
displayed cytotoxic property at 200mM concentration, while quite a few diterpenes were 
found to be cytotoxic even up to 50mM in concentration (Awale et al., 2003b). Another 
diterpene (neoorthosiphonone A) has been discovered as the strongest inhibitor for  
nitric oxide production (Awale et al., 2004). 
2.1.7 Safety and toxicity 
O. stamineus in doses from 0.5, 1.0, 3.0 and 5g/kg is safe and have been used in young 
female Sprague Dawley rats. Fourteen days oral administration of methanol extract of O. 
stamineus in these rats did not produce any death or cause any adverse effects on body 
weight, food consumption, water intake and relative organ weight (Chin et al., 2008). 
 
Standardized extract of O. stamineus had no observable acute effect on the experimental 
animals and was therefore deemed non-toxic. This finding has provided scientific 
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information on the acute effect of the O. stamineus given in a single dose orally at 
5000mg/kg body weight on rats since it did not produce any mortality or alter the 
behavior patterns of the rats. Thus, it was concluded that lethal dose 50 (LD50) of the O. 
stamineus extract is more than 5000mg/kg body weight (Abdullah and Ismail, 2009). 
Accidently, a third confirmatory observation reported that the LD50 of the O. stamineus 
extract is much higher than the highest dose employed in a study by Abdullah and Ismail 
(2009). This was proven while they were investigating the antipyretic effect of O. 
stamineus on rats. They showed that the leaves extract of O. stamineus showed a 
significant effect in yeast-induced elevation of body temperature (Yam et al., 2009). 
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2.2 Honey 
Honey is a natural foodstuff and it is considered as the most popular balanced diet for all 
ages. Characteristic features include: it does not get spoiled, does not need refrigeration 
and can be stored at room temperature. Honey is made by honey-bees from the nectar of 
flowers or secretions from other parts of the plants. Honey is stored in the honeycomb of 
beehives. One tablespoon of honey contains 64 calories. It is an average mixture of 82% 
carbohydrates, 17% water, proteins, amino acids, vitamins and minerals. Honey is also 
used as medicinal treatment for clinical conditions such as  gastrointestinal tract 
problems, ophthalmic lesions, wound healing and burns (Khan et al., 2007). 
  
Tualang honey come from Malay language with reference to the number of giant 
honeybee colonies in Tualang trees. “Lebah camok” refers to less than seven colonies on 
a tree, while “Lebah Tualang” is a much larger aggregation found only in extensive 
forest areas on the huge Koompassia tree, usually a few dozen to nearly 200 colonies as 
shown in Fig. 2.2 (Roubik et al., 2005).  
 
Fig. 2.2 Aggregation of honeybee nests (Apis dorsata) in the high branches of a forest tree, 
Koompassia excelsa. Photograph by T. Inoue (Roubik et al, 2005). 
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2.2.1 Medicinal uses  
Honey is important not only for its nutritional properties but also for its functional and 
biological properties like antioxidant, anti-inflammatory, antibacterial, antiviral and 
antiulcerous activities as well as have the capacity for the inhibition of enzymatic 
browning which is a reaction during fruit and vegetable processing for obtaining juices 
and preserves. These activities are mainly attributed to the phenolic compounds such as 
flavonoids which are present in all types of honey with different percentage depending 
on the geographical areas, source of honeybee food and climate (Viuda-Martos et al., 
2008). 
2.2.2 Antimicrobial activity 
Many literatures on the antibacterial effect of honey emphasize on the type of honey and 
geographical region. Most literature found that the antimicrobial effect of honey depends 
on the hydrogen peroxide content of honey in some types or due to phytochemical or 
entomological (bees) factors. These researches are still ongoing (Allen et al., 1991; 
Miorin et al., 2003; Temaru et al., 2007; Irish et al., 2008). 
2.2.3 Antioxidant activity 
Antioxidant properties of seven types of honey from various floral sources were  
determined in comparison with sugars analogue by Gheldof and Engeseth (2002). All 
types of honey were more effective as antioxidant than the sugars analogue. 
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Different types of honey come in dark and light colours. The phenolic compounds from 
honey extract were proven as antioxidant and antimicrobial agents. The dark coloured 
honey has stronger antibacterial effect than the light coloured honey. Moreover, these 
compounds are reported to exhibit anticarcinogenic, anti-inflammatory, antiatherogenic, 
antithrombotic, immune modulating and analgesic as well as antioxidant activities 
(Estevinho et al., 2008).  
2.2.4 Anticarcinogenic activity 
Antimutagenic properties of honey were detected using Ames assay by Wang et al, 
(2002). Regarding the anticancer effects of honey, very few resources are available to 
substantiate the antineoplastic activity on cancer cell lines in-vitro and in-vivo. When 
honey was applied on bladder cancer cell lines that were tested for antiproliferative 
effect through MTT assay and flow cytometry, results showed significant inhibition of 
the proliferation of bladder cancer cell lines more than the mixed sugar solution. It 
showed an important conclusion that hyperosmolarity of honey alone cannot explain the 
drastic inhibitory effect on tumours.  Therefore, flow cytometry might be useful to 
confirm the apoptotic effect of honey on bladder cancer cell lines (Swellam et al, 2003).   
 
Swellam et al, (2003) implanted bladder cancer cell lines suspension in 100 abdomens of 
mice. After the tumour reached 100 -150 mm³, the mice were divided into groups 
depending on honey concentration fed orally in comparison with control (with no honey 
treatment). Their results showed significant difference between the final tumour volume 
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and weight in the honey treated groups and the control group. This confirmed the 
inhibitory effect of honey on tumour growth in-vivo. 
  
In an in-vivo study, mice were injected with single cancer cell suspension 
subcutaneously and intravenously to generate metastasis. Honey products were applied 
orally and systemically before and after the cancer inoculation. The results showed 
reduced tumour growth and inhibited metastasis formation with honey  products (Orsolic 
et al., 2005).  
 
The use of honey in cancer surgery was assessed where local honey treatment was 
applied pre-and post-cancer inoculation on experimental mice. Tumour growth could not 
be detected even microscopically when treated with honey while in all control group 
with no honey treatment, the tumour was palpable and confirmed histopathologically. 
These findings indicated that honey might prevent tumour implantation when applied 
locally (Hamzaoglu et al., 2000).  
  2.2.5 Wound and burn healing and surgery  
Many trials for the effect of honey on burn healing were reviewed by Wallace (2009). 
She concluded that honey application on burns make better healing than conventional 
dressing. Honey enzyme content like amylase play an important role in synergistic 
antibacterial effect when honey was mixed with starch, which can be applied safely on 
wounds or inserted into cavities and sinuses to clear out infection (Boukraa and Amara, 
2008). 
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2.2.6 Synergistic activity 
The antimicrobial effect of honey on some oral bacterial species was investigated using 
different types of honey with control solution from carbohydrate concentrations. Some 
bacterial species were found sensitive to honey at concentrations lower than that 
observed for the carbohydrate control.  This indicated that there may be unidentified 
components present in honey that is active against these organisms (Basson and Grobler, 
2008). 
  
The effect of honey on coagulase-negative staphylococci was tested in-vitro in 
comparison with osmolar solution equivalent to the osmolarity of honey. It was shown 
that the effect of honey was eight times potent in killing of the antibiotic resistant 
bacteria than osmolar control solution, indicating that honey applied to skin at insertion 
points of medical devices may have a role in the treatment or prevention of infections by 
coagulase-negative staphylococci (French et al., 2005). 
 
Commonly, honey is used in the mixed form with other food or medicinal herbs for the 
synergistic effect of honey (Boukraa and Amara, 2008). Many researches are targeting 
to find a novel synergistic medicine by mixing flavonoids to get the maximum effect 
with no harm on human health (Harborne and Williams, 2000; Campbell et al., 2006). 
However, these researches are still ongoing. 
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2.3 Oral Squamous Cell Carcinoma 
Oral Squamous Cell Carcinoma (OSCC) is the most common cancer of the head and 
neck. Although oral cancer that is detected early is highly curable, more than 50% of 
oral cancer patients present with advanced disease, and fewer than 30% of these patients 
can be cured (Marcus et al., 2004). Studies in the past decade showed that concurrent 
chemo-radiotherapy has the potential to improve the overall survival of patients with 
head and neck OSCC (Pignon et al., 2000).  
 
OSCC presents a significant health problem that affects over half a million people in the 
world each year (Parkin et al., 1993). General treatment modalities of OSCC are 
surgery, radiotherapy and chemotherapy. A number of chemotherapeutic agents have 
been used to treat OSCC (Forastiere et al., 1992).  
 
The survival rate of OSCC patients has not improved with current chemotherapeutic 
agents. For the improvement of clinical outcome, it is necessary to verify the molecular 
mechanisms of chemotherapeutic agents and to apply the combination of 
chemotherapeutic agents that induce synergistic antitumor activity (Kim et al., 2007). 
Many recent researches use OSCC to detect the anticancer activities of such drugs or 
herb extracts (Tong et al., 2000; Zhang et al., 2003; Xu et al., 2005; Kim et al., 2007; 
Otsubo et al., 2007; Pan et al., 2007; Wu et al., 2007; Yang et al., 2007; Lee et al., 2008; 
Yang et al., 2008). 
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OSCC represents a malignant transformation of keratinocytes in stratified squamous 
epithelium. It is the most common cancer of the oral cavity, accounting for 90% of all 
diagnosed oral malignancies, and it accounts for approximately 3% of all human 
malignancies. Some OSCCs invade adjacent bone, some metastasize to cervical lymph 
nodes or distant organs, while other OSCCs follow a more indolent course (Erdem et al., 
2007).  
 
Recently, cancer chemoprevention using food and medicinal herbs has been regarded as 
one of the most visible fields for cancer control (Jo et al., 2004). Considering their safety 
and fewer side effects, some herbal drugs have been reported to possess 
chemotherapeutic effects which exhibit effective anticancer activity on head and neck 
squamous cell carcinoma in-vitro and in-vivo (Zhang et al., 2003). 
 
Furthermore, a growing number of in-vitro studies have been conducted on the potential 
anticancer activity of flavonoids in various cell systems including human oral cancer 
(Ren et al., 2003; Hsu et al., 2004). For example, Elattar and Virji (2000) found 
inhibitory effects of tea polyphenols, curcumin, genistein, quercetin and cisplatin on the 
growth of oral cancer cell lines SCC-25. In addition, (Haghiac and Walle, 2005) also 
gave evidence that quercetin (flavonoid) induces necrosis and apoptosis in SCC-9 (Yang 
et al., 2008). 
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2.4 Human Osteosarcoma 
Osteosarcoma is a highly malignant and rare disease with an incidence of around 3 per 
million (Dorfman and Czerniak, 1995). Osteosarcomas that arise from the jaw account 
for 2.1% of all malignant oral and maxillofacial tumours (Chen et al., 2008b). In a recent 
systemic review of prognostic factors in osteosarcoma, it was concluded that 
chemotherapy may assume independent prognostic factor where the development of 
novel therapeutic agents targeting the malignant behaviour of osteosarcoma cells is 
important to improve the prognosis of patients (Bramer et al., 2009). 
 
The risk of early metastases particularly in the lung is high with 20% of all patients with 
osteosarcoma having solid metastases when first diagnosed. The rate of micrometastases 
is estimated to be 80%. The 5-year survival of the typical osteosarcoma is now 60% –
70%. The prognosis for recurrences and tumours with primary metastases is still poor 
(Carrle and Bielack, 2006). 
 
Isoflavone derivatives that belong to flavonoids were proven as anticancer agents by 
inducing apoptosis on osteosarcoma cell lines. This indicates that isoflavone is a 
promising chemotherapeutic agent worthy of further development for treatment of 
human osteosarcoma cells (Chen et al., 2008a; Hou et al., 2008). 
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2.5 Apoptosis 
Apoptosis or programmed cell death is an essential physiological process that plays a 
critical role in development and tissue homeostasis (Zimmermann et al., 2001). The goal 
of cancer chemoprevention is to inhibit the induction and suppress the progression of 
pre-neoplastic lesions to invasive cancer by using specific natural or synthetic chemicals 
(Sun, 2001). Further understanding of the effects of potential chemopreventive agents on 
specific components of the pathways that lead to apoptosis may provide a rational 
approach to use such agents either alone or in combination with other agents to enhance 
apoptosis as a strategy for effective chemoprevention of cancer (Jo et al., 2004).  
 
There are two main pathways leading to apoptosis. The first of these depends on the 
participation of mitochondria and the second pathway involves the interaction of death 
receptors with its ligands (Li et al., 2007a). 
2.5.1 Apoptosis features 
 
Apoptosis, a physiological cell suicide plays an important role in embryogenesis, 
metamorphosis, cellular homeostasis and as a defensive mechanism to remove infected, 
mutated or damaged cells. It is characterized by loss of cellular contact with the matrix, 
cytoplasmic contraction, chromatin condensation, plasma membrane blebbing and DNA 
fragmentation into large and small oligosomes. There are two major pathways of 
apoptosis: the death receptor pathway and the mitochondrial pathway. There is recent 
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evidence to suggest that these two pathways may be linked in certain cell types (Gupta, 
2000a; Gupta, 2000b). 
 
Membrane blebbing, cell shrinkage, protein fragmentation, chromatin condensation and 
DNA degradation followed by rapid engulfment of cell debris by neighboring cells was 
also explained by Borner (2003).  
 
In the early stage of apoptosis, which occurs at the cell surface, one of the plasma 
membrane alterations is the translocation of phosphatidylserine (PS) from the inner side 
of the plasma membrane to the outer layer, by which PS becomes exposed at the 
external surface of the cell. Annexin V-FITC is a phospholipid-binding protein with a 
high affinity for PS. Previous molecular  process can be identified by flow cytometry 
analysis to quantify the percentage of apoptotic cells, the simplest way to look for 
apoptosis bodies which remain as a gold standard with light microscopy or by the 
Hoechst stain under fluorescence microscope (Vermes et al., 2000). 
2.5.2 Importance of apoptosis 
Defects in the regulation of apoptosis contribute to many diseases including pathologies 
associated with cell loss (e.g. stroke, heart failure, neurodegeneration, AIDS) and 
disorders characterized by a failure to eliminate harmful cells (e.g. cancer, 
autoimmunity). Progress in identifying apoptosis-relevant targets for drug discovery 
opens wide opportunities for new and more effective treatments for many medical 
illnesses currently lacking adequate treatments (Reed, 2001). 
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Apoptotic cell death is a physiological mechanism that eliminates unwanted cells by 
triggering the cell‟s intrinsic suicide program. Impairment of the apoptotic mechanism 
ultimately generates a pathological condition that includes developmental defects like 
autoimmune diseases, neurodegeneration or cancerous neoplasia (Reed, 2001). 
2.5.3 Apoptosis inducers  
Anticancer researches are directed towards innovations to find safe anticancer agents or 
drugs for the human body and harmful only for cancer cells by making selective 
mechanism which produce apoptotic effect on cancer cells. Most of these efforts focus 
on the natural plants that have medicinal uses.  
 
Apoptosis has been characterized as a fundamental cellular activity to maintain the 
physiological balance of the organism. It is also involved in the immune system and 
plays a necessary role as a protective mechanism against carcinogenesis by eliminating 
damaged cells or abnormal excess cells which have proliferated owing to various 
inductions of chemical agents. Emerging evidence has demonstrated that the anticancer 
activities of certain chemotherapeutic agents are involved in the induction of apoptosis, 
which is regarded as the preferred way to manage cancer (Schuchmann and Galle, 
2004). 
 
In-vitro and in-vivo studies suggest that dietary flavonols could inhibit cancer in humans 
(Hollman and Katan, 1999). A prospective study involving about 10,000 men and 
women aged 15±99 years was carried out in Finland. After 24 years of follow-up, a 
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reduction in risk of lung cancer of about 50% was found in the highest quartile of those 
with flavonol intake (Knekt et al., 1997). 
 
There are already numerous natural products known, which control apoptotic pathways 
at different points. Progress in this field will depend on the cooperation of natural 
product chemistry, synthesis and medicinal chemistry. Natural products are potential 
lead structures for future drugs to cure apoptotic misregulation (Daniel et al., 2006). 
 
Many recent in-vitro and in-vivo studies have concentrated on the beneficial effect of 
dietary and herbal flavonoids. The effect was related to cancer prevention and treatment 
(Kanno et al., 2005) on hepatoma, breast, cervix, stomach and pancreas cancer cell lines. 
Those flavonoids induced a positive apoptotic effect on all previously mentioned cancer 
cell lines. Horinaka et al (2006) studied the natural flavonoid (apigenin) that induced 
apoptotic effect on leukemia, prostate and colon cancer cell lines. Flavonoids have been 
shown to induce apoptosis in some cancer cell lines while sparing normal cells. The 
molecular mechanisms by which flavonoids induce apoptosis have not yet been 
clarified. Flavonoids are generally nontoxic and manifest a diverse range of beneficial 
biological activities. 
 
The role of dietary flavonoids in cancer prevention has been widely discussed. There is 
much evidence that flavonoids have important effects on inhibiting carcinogenesis. 
Epidemiological studies have provided data that high dietary intake of flavonoids with 
fruits and vegetables could be associated with low cancer prevalence in humans. This is 
supported by a multitude of in-vitro and in-vivo studies, which showed that flavonoids 
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may inhibit various stages in the carcinogenesis process, namely tumour initiation, 
promotion and progression (Ren et al., 2003). 
 
Based on the in-vitro and in-vivo studies, it is understood that many mechanisms of 
action may be involved. These include carcinogen inactivation, antiproliferation, cell 
cycle arrest, induction of apoptosis and differentiation, inhibition of angiogenesis, 
antioxidation and reversal of multidrug resistance or a combination of these 
mechanisms. 
 
Tumor cell apoptosis is characterized by cellular rounding-up, cytoplasmic contraction, 
plasma membrane blebbing, chromatin condensation, DNA fragmentation and many 
biochemical characteristics, including the activation of death receptor pathway, 
mitochondrial pathway and/or caspases cascades (Gupta, 2001; Daniel et al., 2006).  
 
 Ueda et al (2002) investigated Vietnamese plants extracts and their apoptotic effect on 
fibrosarcoma.  Herbal drugs that were used traditionally tested on ovarian cancer cell 
lines showed apoptotic effect (Zhu et al., 2005). Moreover, the herbal extract fractions 
were tested for apoptotic effect on hepatoma and colorectal cancer cell lines (Wang et 
al., 2005). Studies have shown that litchi fruits (Litchi chinensis) gave apoptotic effect 
on oral cancer cell lines (Xu et al., 2005). The same effect was noticed with antrodia 
cinnamomea (antrodia camphorate) on hepatoma cancer cell lines (Kuo et al., 2006). 
 
In the progress for plant medical industry, their pure compounds of fractions are 
formulated for medical uses. Before this stage, it should pass through many experiments 
